| |
|
|
|
Corbus Pharma
|
|
6.75 -0.10 (-1.46%) |
9/19/2017 4:00pm |
|
Open: |
6.95 |
Pre close: |
6.85 |
Target:
|
8.27 
|
|
High: |
7.00 |
Low: |
6.65 |
Resistance:
|
7.08
7.90
|
|
Volume: |
369,599 |
Market Cap: |
338.99M |
Support:
|
5.75
4.78
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.77
 |
MACD |
MACD(12,26):
|
0.10 |
|
MA(20): |
6.92 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
6.42 |
Stochastic Oscillator |
%K(14,3):
|
25.56 |
|
MA(250): |
7.21 |
%D(3): |
29.91 |
|
Average Volume(K) |
3-Month: |
45930
|
52-Week |
High:
|
10.78 |
|
10-Days: |
33560 |
Low: |
4.65 |
|
RSI |
RSI(14):
|
50.62 |
Change(%): |
-9.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.600 |
Return on Equity (ttm) |
-100.2 |
Shares Out. (M) |
50.22 |
|
EPS Est. Current Year |
-0.660 |
Return on Assets (ttm) |
-51.4 |
Shares Float (M) |
41.86 |
|
EPS Est. Next Year |
-0.650 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.59 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
-11.7 |
% Held by Institutions |
31.38 |
|
Forward EPS |
-0.650 |
Gross Profit (p.s.) |
0.038 |
Shares Short (K) |
7070 |
|
Book Value (p.s.) |
0.750 |
EBITDA (p.s.) |
-0.548 |
P/E |
-11.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.88 |
P/S |
5649750016.00 |
|
Operating Margin |
-1001.06 |
Levered Free Cash Flow
(M) |
-10.85 |
P/CF |
-16.23 |
|
|
|
|
|
|
|
